The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Background: Pre-exposure prophylaxis (PrEP) with daily oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prevents HIV infection. The safety and feasibility of HIV PrEP in the setting of hepatitis B virus (HBV) infection w...

Full description

Saved in:
Bibliographic Details
Main Authors: Solomon M., Schechter M., Liu A., McManhan V., Guanira J., Hance R., Chariyalertsak S., Mayer K., Grant R., Bekker L., Buchbinder S., Casapia M., Kallas E., Lama J., Montoya O., Veloso V.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959166158&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/42660
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959166158&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/42660

Similar Items